Literature DB >> 15650758

Moderate to severe obstructive sleep apnoea patients is associated with a higher incidence of visual field defect.

C S L Tsang1, S L Chong, C K Ho, M F Li.   

Abstract

PURPOSE: To compare the visual fields (VFs) and optic nerve head changes between obstructive sleep apnoea (OSA) in normotensive patients and an age-matched non-OSA population.
DESIGN: Case-control study. PARTICIPANTS: A total of 41 ethnic Chinese patients diagnosed with moderate to severe OSA referred from the Sleep Laboratory, ENT Department, Tuen Mun Hospital. A total of 35 age-matched non-OSA subjects recruited from the Ophthalmology Department, North District Hospital.
METHODS: Comprehensive ophthalmological and systemic history, complete ophthalmological examination, including central-30 computerized perimetry for all studied patients. MAIN OUTCOME MEASURES: Polysomnographic data, VF indices, optic disc changes.
RESULTS: In the OSA arm, VF indices were significantly subnormal and the incidence of suspicious glaucomatous disc changes was four times higher than that of the control arm. None of the studied patients suffered from any form of anterior segment complications.
CONCLUSIONS: Moderate to severe OSA is associated with a higher incidence of VF defect and glaucomatous optic nerve changes.

Entities:  

Mesh:

Year:  2006        PMID: 15650758     DOI: 10.1038/sj.eye.6701785

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  37 in total

1.  Ocular surface assessment in patients with obstructive sleep apnea-hypopnea syndrome.

Authors:  Mutlu Acar; Hikmet Firat; Ugur Acar; Sadik Ardic
Journal:  Sleep Breath       Date:  2012-06-05       Impact factor: 2.816

2.  [Ocular risks in obstructive sleep apnea syndrome].

Authors:  A Steindel; C Lautenschläger; H G Struck
Journal:  Ophthalmologe       Date:  2010-11       Impact factor: 1.059

Review 3.  Obstructive sleep apnea-hypopnea syndrome (OSAHS) and glaucomatous optic neuropathy.

Authors:  Consuelo Pérez-Rico; Esperanza Gutiérrez-Díaz; Enrique Mencía-Gutiérrez; María Josefa Díaz-de-Atauri; Román Blanco
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-05-25       Impact factor: 3.117

4.  [Prevalence of glaucoma in obstructive sleep apnea].

Authors:  N J Gross; J Funk; M Pache; M van der List; A Laubmann-Volz; S Sorichter; W A Lagrèze
Journal:  Ophthalmologe       Date:  2015-07       Impact factor: 1.059

5.  Retinal and optic nerve evaluation by optical coherence tomography in adults with obstructive sleep apnea-hypopnea syndrome (OSAHS).

Authors:  Paula Casas; Francisco J Ascaso; Eugenio Vicente; Gloria Tejero-Garcés; María I Adiego; José A Cristóbal
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-02-03       Impact factor: 3.117

6.  Prevalence of glaucoma in patients with moderate to severe obstructive sleep apnea: ocular morbidity and outcomes in a 3 year follow-up study.

Authors:  S P Hashim; F A Al Mansouri; M Farouk; A A Al Hashemi; R Singh
Journal:  Eye (Lond)       Date:  2014-08-15       Impact factor: 3.775

7.  Changes of visual field and optic nerve fiber layer in patients with OSAS.

Authors:  Chen Xin; Wei Zhang; Li Wang; Diya Yang; Jun Wang
Journal:  Sleep Breath       Date:  2014-05-08       Impact factor: 2.816

8.  Correlation between structural progression in glaucoma and obstructive sleep apnea.

Authors:  Yuan-Yao Fan; Wei-Wen Su; Chun-Hsiu Liu; Henry Shen-Lih Chen; Shiu-Chen Wu; Shirley H L Chang; Kuan-Jen Chen; Wei-Chi Wu; Ning-Hung Chen; Hsueh-Yu Li; Ming-Hui Sun
Journal:  Eye (Lond)       Date:  2019-04-10       Impact factor: 3.775

9.  Obstructive sleep apnea/hypopnea syndrome increases glaucoma risk: evidence from a meta-analysis.

Authors:  Xinhua Wu; Huanbo Liu
Journal:  Int J Clin Exp Med       Date:  2015-01-15

10.  Parafoveal and optic disc vessel density in patients with obstructive sleep apnea syndrome: an optical coherence tomography angiography study.

Authors:  Laura Moyal; Esther Blumen-Ohana; Marc Blumen; Cybele Blatrix; Frederic Chabolle; Jean-Philippe Nordmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-03-25       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.